News

A preclinical study investigating the use of a trio of drugs for treating pancreatic cancer and preventing metastasis has shown promise.

Researchers have discovered a link between two of the most common genetic changes that cause cells to become cancerous.

A recent study has highlighted the importance of early, honest and transparent communication during cancer diagnosis and treatment.

Scientists at St. Jude Children’s Research Hospital have developed a method that may be able to improve CAR T-cell therapies by identifying the early cells that become effective at killing cancer.

Chemists have now discovered how epidermal growth factor receptor changes its shape when it binds to its target, and how those changes trigger cells to grow and proliferate.

Prenatal exposure to endocrine-disrupting chemicals has been shown to be associated with rising cases of non-alcoholic fatty liver disease, a potentially cancer-causing condition.

Research suggests that marital status could be an important contributory factor in predicting long term survival in people with early stage gastric cancer.

Forty-two hereditary genes have been identified that increase a person's risk of accumulating DNA mutations that correlate with a higher risk of developing cancer.

Researchers have definitively linked the function of a specific domain of proteins important in plant and microbe biology to a cancer trigger in humans, creating opportunities for the development of selective drug therapies to fight a variety of cancers.

Researchers have developed a method that uses big data to scan thousands of DNA samples and find cancerous mutations in cells.